b16f10 melanoma cell line Search Results


90
KU Leuven lewis llcs
WT or Apoa1 KO C57Bl6/J mice were inoculated with 0.5 × 10 6 syngeneic tumor cells either subcutaneously in the right flank (Panc02, <t>B16F10,</t> lung carcinoma cell) or orthotopically in the second mammary fat pad (E0771). (A) Tumor growth kinetics and tumor weight at experimental end stage of the Panc02 pancreatic-cancer model (n = 7/7). (B) Tumor growth kinetics and tumor weight at experimental end stage of the B16F10 melanoma model (n = 13/10 WT and Apoa1 KO mice, respectively). (C) Tumor growth kinetics and tumor weight at experimental end stage of the lung carcinoma cell lung cancer model (n = 9/8). (D) Tumor growth kinetics and tumor weight at experimental end stage of the E0771 breast cancer model (n = 10/13; * P < 0.05; unpaired t test for A, B, C, D).
Lewis Llcs, supplied by KU Leuven, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/b16f10+melanoma+cell+line/melanoma+cell+line+b16f10/pmc09112193-179-1-32
Average 90 stars, based on 1 article reviews
lewis llcs - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Biofield Corporation human keratinocytes (hacat) cell line
WT or Apoa1 KO C57Bl6/J mice were inoculated with 0.5 × 10 6 syngeneic tumor cells either subcutaneously in the right flank (Panc02, <t>B16F10,</t> lung carcinoma cell) or orthotopically in the second mammary fat pad (E0771). (A) Tumor growth kinetics and tumor weight at experimental end stage of the Panc02 pancreatic-cancer model (n = 7/7). (B) Tumor growth kinetics and tumor weight at experimental end stage of the B16F10 melanoma model (n = 13/10 WT and Apoa1 KO mice, respectively). (C) Tumor growth kinetics and tumor weight at experimental end stage of the lung carcinoma cell lung cancer model (n = 9/8). (D) Tumor growth kinetics and tumor weight at experimental end stage of the E0771 breast cancer model (n = 10/13; * P < 0.05; unpaired t test for A, B, C, D).
Human Keratinocytes (Hacat) Cell Line, supplied by Biofield Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/b16f10+melanoma+cell+line/melanogenesis+mouse+melanoma++b16+f10++cell+line/10__11648_slash_j__ejpm__20170502__11-55-52-21
Average 90 stars, based on 1 article reviews
human keratinocytes (hacat) cell line - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
CH Instruments b16f10-ovaþvegf-chi cells
WT or Apoa1 KO C57Bl6/J mice were inoculated with 0.5 × 10 6 syngeneic tumor cells either subcutaneously in the right flank (Panc02, <t>B16F10,</t> lung carcinoma cell) or orthotopically in the second mammary fat pad (E0771). (A) Tumor growth kinetics and tumor weight at experimental end stage of the Panc02 pancreatic-cancer model (n = 7/7). (B) Tumor growth kinetics and tumor weight at experimental end stage of the B16F10 melanoma model (n = 13/10 WT and Apoa1 KO mice, respectively). (C) Tumor growth kinetics and tumor weight at experimental end stage of the lung carcinoma cell lung cancer model (n = 9/8). (D) Tumor growth kinetics and tumor weight at experimental end stage of the E0771 breast cancer model (n = 10/13; * P < 0.05; unpaired t test for A, B, C, D).
B16f10 Ovaþvegf Chi Cells, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/b16f10+melanoma+cell+line/mice+melanoma+cell+line+b16+f10/10__1158_slash_2326___6066__cir___20___0784-98-5-5
Average 90 stars, based on 1 article reviews
b16f10-ovaþvegf-chi cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Farmitalia Carlo Erba Srl b16f10 mouse melanoma cell line
WT or Apoa1 KO C57Bl6/J mice were inoculated with 0.5 × 10 6 syngeneic tumor cells either subcutaneously in the right flank (Panc02, <t>B16F10,</t> lung carcinoma cell) or orthotopically in the second mammary fat pad (E0771). (A) Tumor growth kinetics and tumor weight at experimental end stage of the Panc02 pancreatic-cancer model (n = 7/7). (B) Tumor growth kinetics and tumor weight at experimental end stage of the B16F10 melanoma model (n = 13/10 WT and Apoa1 KO mice, respectively). (C) Tumor growth kinetics and tumor weight at experimental end stage of the lung carcinoma cell lung cancer model (n = 9/8). (D) Tumor growth kinetics and tumor weight at experimental end stage of the E0771 breast cancer model (n = 10/13; * P < 0.05; unpaired t test for A, B, C, D).
B16f10 Mouse Melanoma Cell Line, supplied by Farmitalia Carlo Erba Srl, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/b16f10+melanoma+cell+line/b16f10+mouse+melanoma+cell+line/2R2829lM0ivDgITVEhiTw2bY2kSAhyCOR8iRTuN1kQPAAK33xI0pIiEcoO3IznQeD4WX1TpYns5XsozhK-32-6-16
Average 90 stars, based on 1 article reviews
b16f10 mouse melanoma cell line - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Cell Genesys b16-f10 melanoma tumor cell line
WT or Apoa1 KO C57Bl6/J mice were inoculated with 0.5 × 10 6 syngeneic tumor cells either subcutaneously in the right flank (Panc02, <t>B16F10,</t> lung carcinoma cell) or orthotopically in the second mammary fat pad (E0771). (A) Tumor growth kinetics and tumor weight at experimental end stage of the Panc02 pancreatic-cancer model (n = 7/7). (B) Tumor growth kinetics and tumor weight at experimental end stage of the B16F10 melanoma model (n = 13/10 WT and Apoa1 KO mice, respectively). (C) Tumor growth kinetics and tumor weight at experimental end stage of the lung carcinoma cell lung cancer model (n = 9/8). (D) Tumor growth kinetics and tumor weight at experimental end stage of the E0771 breast cancer model (n = 10/13; * P < 0.05; unpaired t test for A, B, C, D).
B16 F10 Melanoma Tumor Cell Line, supplied by Cell Genesys, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/b16f10+melanoma+cell+line/b16+f10+melanoma+tumor+cell+line/pmc04037402-97-2-24
Average 90 stars, based on 1 article reviews
b16-f10 melanoma tumor cell line - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

99
ATCC b16-f10
WT or Apoa1 KO C57Bl6/J mice were inoculated with 0.5 × 10 6 syngeneic tumor cells either subcutaneously in the right flank (Panc02, <t>B16F10,</t> lung carcinoma cell) or orthotopically in the second mammary fat pad (E0771). (A) Tumor growth kinetics and tumor weight at experimental end stage of the Panc02 pancreatic-cancer model (n = 7/7). (B) Tumor growth kinetics and tumor weight at experimental end stage of the B16F10 melanoma model (n = 13/10 WT and Apoa1 KO mice, respectively). (C) Tumor growth kinetics and tumor weight at experimental end stage of the lung carcinoma cell lung cancer model (n = 9/8). (D) Tumor growth kinetics and tumor weight at experimental end stage of the E0771 breast cancer model (n = 10/13; * P < 0.05; unpaired t test for A, B, C, D).
B16 F10, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/b16f10+melanoma+cell+line/B16-F10/custom%40crl-6475%4040023152
Average 99 stars, based on 1 article reviews
b16-f10 - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

90
BioCrystal Ltd murine b16f10 melanoma cell line
WT or Apoa1 KO C57Bl6/J mice were inoculated with 0.5 × 10 6 syngeneic tumor cells either subcutaneously in the right flank (Panc02, <t>B16F10,</t> lung carcinoma cell) or orthotopically in the second mammary fat pad (E0771). (A) Tumor growth kinetics and tumor weight at experimental end stage of the Panc02 pancreatic-cancer model (n = 7/7). (B) Tumor growth kinetics and tumor weight at experimental end stage of the B16F10 melanoma model (n = 13/10 WT and Apoa1 KO mice, respectively). (C) Tumor growth kinetics and tumor weight at experimental end stage of the lung carcinoma cell lung cancer model (n = 9/8). (D) Tumor growth kinetics and tumor weight at experimental end stage of the E0771 breast cancer model (n = 10/13; * P < 0.05; unpaired t test for A, B, C, D).
Murine B16f10 Melanoma Cell Line, supplied by BioCrystal Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/b16f10+melanoma+cell+line/murine+b16f10+melanoma+cell+line/10__1097_slash_cmr__0b013e32831bc45a-44-0-10
Average 90 stars, based on 1 article reviews
murine b16f10 melanoma cell line - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
ScienCell b16f10 murine melanoma cell line
WT or Apoa1 KO C57Bl6/J mice were inoculated with 0.5 × 10 6 syngeneic tumor cells either subcutaneously in the right flank (Panc02, <t>B16F10,</t> lung carcinoma cell) or orthotopically in the second mammary fat pad (E0771). (A) Tumor growth kinetics and tumor weight at experimental end stage of the Panc02 pancreatic-cancer model (n = 7/7). (B) Tumor growth kinetics and tumor weight at experimental end stage of the B16F10 melanoma model (n = 13/10 WT and Apoa1 KO mice, respectively). (C) Tumor growth kinetics and tumor weight at experimental end stage of the lung carcinoma cell lung cancer model (n = 9/8). (D) Tumor growth kinetics and tumor weight at experimental end stage of the E0771 breast cancer model (n = 10/13; * P < 0.05; unpaired t test for A, B, C, D).
B16f10 Murine Melanoma Cell Line, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/b16f10+melanoma+cell+line/b16f10+murine+melanoma+cell+line/pm34971733-55-1-21
Average 90 stars, based on 1 article reviews
b16f10 murine melanoma cell line - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


WT or Apoa1 KO C57Bl6/J mice were inoculated with 0.5 × 10 6 syngeneic tumor cells either subcutaneously in the right flank (Panc02, B16F10, lung carcinoma cell) or orthotopically in the second mammary fat pad (E0771). (A) Tumor growth kinetics and tumor weight at experimental end stage of the Panc02 pancreatic-cancer model (n = 7/7). (B) Tumor growth kinetics and tumor weight at experimental end stage of the B16F10 melanoma model (n = 13/10 WT and Apoa1 KO mice, respectively). (C) Tumor growth kinetics and tumor weight at experimental end stage of the lung carcinoma cell lung cancer model (n = 9/8). (D) Tumor growth kinetics and tumor weight at experimental end stage of the E0771 breast cancer model (n = 10/13; * P < 0.05; unpaired t test for A, B, C, D).

Journal: Life Science Alliance

Article Title: The HDL particle composition determines its antitumor activity in pancreatic cancer

doi: 10.26508/lsa.202101317

Figure Lengend Snippet: WT or Apoa1 KO C57Bl6/J mice were inoculated with 0.5 × 10 6 syngeneic tumor cells either subcutaneously in the right flank (Panc02, B16F10, lung carcinoma cell) or orthotopically in the second mammary fat pad (E0771). (A) Tumor growth kinetics and tumor weight at experimental end stage of the Panc02 pancreatic-cancer model (n = 7/7). (B) Tumor growth kinetics and tumor weight at experimental end stage of the B16F10 melanoma model (n = 13/10 WT and Apoa1 KO mice, respectively). (C) Tumor growth kinetics and tumor weight at experimental end stage of the lung carcinoma cell lung cancer model (n = 9/8). (D) Tumor growth kinetics and tumor weight at experimental end stage of the E0771 breast cancer model (n = 10/13; * P < 0.05; unpaired t test for A, B, C, D).

Article Snippet: The murine melanoma cell line B16F10, Lewis LLCs, and the breast adenocarcinoma cell line E0771 were a kind gift of Prof. Dr. Peter Carmeliet and Prof. Massimiliano Mazzone (VIB Vesalius Research Center, KU Leuven) and maintained in DMEM medium supplemented with 10% FCS, 2 mM L-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin (complete DMEM).

Techniques: